Company news
Bolt Biotherapeutics, Inc. news in 2024
Bolt Biotherapeutics, Inc.'s news releases, calls and decks from 2024, newest first.
Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
November 11, 2024
Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting
November 6, 2024
Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm
September 6, 2024
Bolt Biotherapeutics Inc. May Have Violated Securities Regulations And Stakeholders Are Urged To Reach Out To The Schall Law Firm
September 4, 2024
Bolt Biotherapeutics Announces Changes to its Board of Directors
September 3, 2024
Stakeholders Can Contact The Schall Law Firm About Joining A Case Against Bolt Biotherapeutics Inc. For Securities Law Infractions
September 2, 2024
Bolt Biotherapeutics Inc. Is Being Sued For Possibly Engaging In Securities Related Infractions And Shareholders Can Assist The Schall Law Firm
August 31, 2024
Bolt Biotherapeutics Inc. Is Being Sued For Securities Law Violations And Stockholders Are Invited To Contact The Schall Law Firm
August 29, 2024
The Schall Law Firm Is Suing Bolt Biotherapeutics, Inc. For Securities Law Violations And Stakeholders Are Urged To Join
August 23, 2024
Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
August 12, 2024
Bolt Biotherapeutics, Inc. (BOLT) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates
May 30, 2024
Bolt Biotherapeutics, Inc. (BOLT) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
May 30, 2024
Bolt Biotherapeutics, Inc. Being Investigated on Behalf of Bolt Biotherapeutics, Inc. Investors. Contact Levi & Korsinsky For Details
May 28, 2024
Did Bolt Biotherapeutics, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - BOLT
May 22, 2024
Bolt Biotherapeutics, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - BOLT
May 22, 2024
Lost Money on Bolt Biotherapeutics, Inc. (BOLT)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
May 21, 2024
ATTENTION BOLT SHAREHOLDERS: Investors who Lost Money on Bolt Biotherapeutics, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation
May 20, 2024
BOLT ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Bolt Biotherapeutics, Inc. Shareholders Who Lost Money
May 16, 2024
Bolt Biotherapeutics Reports First Quarter 2024 Results, Announces Strategic Pipeline Prioritization and Changes to Leadership Team
May 13, 2024
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
March 20, 2024
Calls in 2024
Decks in 2024
- Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting 2024
Conference · 15 slides · 2024